• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CGEN:US

8.8300 USD 0.3800 4.50%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Compugen Ltd (CGEN)

Open: 8.4600 Day's Range: 8.1600 - 9.0500 Volume: 1,617,759
Previous Close: 8.4500 52wk Range: 6.2700 - 14.3200 1-Yr Rtn: +7.42%

Stock Chart for CGEN

No chart data available.
  • CGEN:US 8.8300
  • 1D
  • 1M
  • 1Y
8.4500
Interactive CGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CGEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2700
Est. EPS (USD) (12/2014) -0.3270
Est. PEG Ratio -
Market Cap (M USD) 428.07
Shares Outstanding (M) 48.48
30 Day Average Volume 255,519
Price/Book (mrq) 4.0264
Price/Sale (ttm) 52.5236
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CGEN

Compugen Ltd. develops solutions in the field of computational genomics. The Company provides its gene discovery tools to pharmaceutical, biotechnology, and other life sciences through its Web site, labOnWeb.com. Compugen is also seeking to commercialize the genes and proteins it discovers.

Anat Cohen-DayagPresident/CEOAri KrashinChief Financial Officer
John J HunterVP:Antibody Research & Dev
More Company Profile & Key Executives for CGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil